WASHINGTON — Allotrope Foundation – a consortium of leading pharmaceutical and biotech companies – selected Osthus Inc. as the architect of its much anticipated open framework for laboratory data. The scope of services that Osthus will provide includes consulting services to Allotrope, as well as the design, coding and implementation of the framework. “During the […]
SAN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its Board of Directors has authorized a review of potential strategic alternatives for its Genetic Analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the […]
SAN DIEGO — Illumina (NASDAQ:ILMN) today announced it has appointed Dr. Richard Klausner as Senior Vice President and Chief Medical Officer. Dr. Klausner will report to President and Chief Executive Officer Jay Flatley and will lead Illumina’s strategies for advancing genomics into clinical medicine and public health. He will also become part of Illumina’s executive […]
LONDON — Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced Accelrys Insight and Accelrys Insight for Excel, completing the roll-out of Accelrys’ next-generation cheminformatics suite and providing an interactive, collaborative environment for rapid and effective decision-making in drug discovery. Accelrys Insight and Accelrys Insight for Excel offer research […]
ADELAIDE, Australia — TGR BioSciences Pty Ltd (TGR), a leading developer of advanced cell-based assay technologies, is pleased to announce a license agreement with Abcam plc, of Cambridge, UK, a producer and distributor of high quality protein research tools. Under the agreement Abcam will develop and manufacture immunoassay products that incorporate TGR’s proprietary CaptSure(TM) assay […]
Palo Alto, CA — Based on data compiled from results of many targeted re-sequencing and exome experiments, users can search using gene symbols, synonyms and gene descriptions giving a visual display of coverage of specific target regions. In addition to providing coverage data, mSeq(TM) reports in a handy summary view of searched gene regions. Features […]
Malmö, Sweden — Umetrics announces a new version of MODDE, a state of the art, off-the-shelf, Windows based software solution for Design of Experiments (DOE). MODDE 10 sets a new standard for ease of use with user friendly wizards which take the user through all the steps of planning, analyzing, interpreting and understanding the results. […]
Shirley, NY — After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (https://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official signing ceremony will held on Oct. 1. According to protocols, Luciferase from Vibrio fischeri has been used in a […]
Shimadzu has introduced its Method Package for Primary Metabolites, designed for the simultaneous analysis of a variety of metabolites associated with central metabolic pathways. Unlike current techniques, such as CE/MS, derivatization followed by GC/MS, or HILIC LC/MS, Shimadzu’s new package allows simultaneous analysis of a wider range of compounds. The new LC/MS/MS Method Package for […]
SEATTLE and CULVER CITY, CA – Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised a $1.5 million seed round led by InterWest Partners and joined by several angel investors. The funds will be used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
